Clinical Trial Update: Gut Microbiome Profiling in Patients With Chronic Heart Failure

View source ↗

Summary

An ongoing clinical trial at Stanford is profiling the gut microbiome in patients with chronic heart failure, including those with heart failure with reduced ej…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction
• Nonischemic Cardiomyopathy

Snippet

Sponsor: Stanford University | Conditions: Heart Failure With Reduced Ejection Fraction, Nonischemic Cardiomyopathy | Status: ENROLLING_BY_INVITATION